Full List Of Stories
World Cup preview: Portugal v Spain, Egypt v Uruguay, Morocco v Iran
The second day of the World Cup brings three games and the promise of the competition’s first meeting of two footballing giants as Portugal and Spain meet in the evening fixture, preceded by an intriguing match-up between Egypt and Uruguay.
Wynnstay Properties records drop in profits despite increased property income
Property investment firm Wynnstay Properties on Thursday revealed a drop in profits, despite an increase in property income due to new acquisitions in its financial year ended 25 March.
Xtract Resources lauds 'substantial' improvement in gold production
Metals and minerals producer Xtract Resources on Thursday confirmed a "substantial" improvement in current quarter alluvial mining contractor gold production to date at the Manica concession.
May's government risks collapse over 'meaningful vote' dispute
Theresa May’s government is in danger of crumbling if party rebels defeat her Brexit deal with the EU, a senior Tory MP has warned.
ITM Power sees pipeline growth, but 'one-offs' to result in full-year cash loss
Energy storage and clean fuel firm ITM Power on Thursday released a pre-close trading update showing strong growth in its orders and tender opportunity pipelines, although higher-than-expected costs were expected to result in a cash loss.
Sky secures broadcast rights for more Serie A games in Italy
Sky's Italian arm won the rights to broadcast twice as many Serie A matches at third of the previous cost, after it split the broadcast right with Perform Group for a total of €973m per season.
Magnolia Petroleum to sell 31 wells to tackle lending facility
Oil and gas production firm Magnolia Petroleum on Thursday signed a non-binding agreement for the sale of its 31 wells in North Dakota for a total consideration of $1. 5m.
Duke Royalty Limited cancels exclusive agreement with Oliver Wyman
Alternative capital solutions firm Duke Royalty Limited on Thursday mutually agreed with Oliver Wyman to end an exclusive healthcare collaboration stretching back to 7 September 2015.
Immupharma finds potential alternate indications for Lupus treatment
Drug discovery and development firm Immupharma on Thursday revealed that its pre-clinical work on P140, a peptide being developed as a Lupus treatment, may have other potential indications.